| Dec 25 | Dec 23 | |
|---|---|---|
| Income Statement | ||
| Total Revenue | $ 204.00K | $ 126.04K |
| Gross Profit | $ 0.00 | $ 126.04K |
| Operating Income | $ 71.22K | $ -22.00K |
| EBITDA | $ 71.22K | $ -22.00K |
| Net Income | $ 71.22K | $ -22.00K |
| Balance Sheet | ||
| Cash & Short-Term Investments | $ 6.81K | $ 20.36K |
| Total Assets | $ 499.49M | $ 499.42M |
| Total Debt | $ 0.00 | $ 0.00 |
| Net Debt | $ -6.81K | $ -20.36K |
| Total Liabilities | $ 15.26K | $ 12.82K |
| Stockholders' Equity | $ 499.47M | $ 499.41M |
| Cash Flow | ||
| Free Cash Flow | $ 6.31K | $ -499.44M |
| Operating Cash Flow | $ 6.31K | $ 9.29K |
| Investing Cash Flow | $ 0.00 | $ -499.44M |
| Financing Cash Flow | $ 0.00 | $ 499.42M |
CS Diagnostics Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.